{"id":"https://openalex.org/W2589198547","doi":"https://doi.org/10.2174/1570159x15666170221101054","title":"Beyond Ketamine: New Approaches to the Development of Safer Antidepressants","display_name":"Beyond Ketamine: New Approaches to the Development of Safer Antidepressants","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-23","ids":{"openalex":"https://openalex.org/W2589198547","doi":"https://doi.org/10.2174/1570159x15666170221101054","mag":"2589198547","pmid":"https://pubmed.ncbi.nlm.nih.gov/28228087","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5652016"},"language":"en","primary_location":{"id":"doi:10.2174/1570159x15666170221101054","doi":"https://doi.org/10.2174/1570159x15666170221101054","is_oa":true,"landing_page_url":"https://doi.org/10.2174/1570159x15666170221101054","pdf_url":"http://www.eurekaselect.com/article/81875","source":{"id":"https://openalex.org/S85221069","display_name":"Current Neuropharmacology","issn_l":"1570-159X","issn":["1570-159X","1875-6190"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Neuropharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2589198547"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.eurekaselect.com/article/81875","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039021133","display_name":"Shigeyuki Chaki","orcid":"https://orcid.org/0000-0003-4444-2911","observed_orcids":["https://orcid.org/0000-0003-4444-2911","https://orcid.org/0000-0001-5608-4192"]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shigeyuki Chaki","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5039021133"],"corresponding_institution_ids":["https://openalex.org/I144245601"],"apc_list":null,"apc_paid":null,"fwci":0.854,"has_fulltext":true,"cited_by_count":44,"citation_normalized_percentile":{"value":0.61707036,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"15","issue":"7","first_page":"963","last_page":"976"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.7730000019073486},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.9750000238418579},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.800000011920929},{"id":"https://openalex.org/keywords/r-ketamine","display_name":"(R)-ketamine","score":0.9070000052452087},{"id":"https://openalex.org/keywords/esketamine","display_name":"esketamine","score":0.9169999957084656},{"id":"https://openalex.org/keywords/ketamine-metabolites","display_name":"ketamine metabolites","score":0.9100000262260437},{"id":"https://openalex.org/keywords/hydroxynorketamine","display_name":"hydroxynorketamine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/rapid-antidepressant-effects","display_name":"rapid antidepressant effects","score":0.7319999933242798},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.578000009059906},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.9039999842643738}],"concepts":[{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.9466615915298462},{"id":"https://openalex.org/C2781065190","wikidata":"https://www.wikidata.org/wiki/Q7256512","display_name":"Psychotomimetic","level":4,"score":0.8970807790756226},{"id":"https://openalex.org/C2778807096","wikidata":"https://www.wikidata.org/wiki/Q900394","display_name":"Dissociative","level":2,"score":0.7526758909225464},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6569888591766357},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.573885977268219},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.5603585839271545},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5042895078659058},{"id":"https://openalex.org/C2776654903","wikidata":"https://www.wikidata.org/wiki/Q2601463","display_name":"SAFER","level":2,"score":0.417039155960083},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40073496103286743},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.36569181084632874},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3392929434776306},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3017895221710205},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1301696002483368},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12697207927703857},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.11552506685256958},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.07053065299987793},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.06382247805595398},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.2174/1570159x15666170221101054","doi":"https://doi.org/10.2174/1570159x15666170221101054","is_oa":true,"landing_page_url":"https://doi.org/10.2174/1570159x15666170221101054","pdf_url":"http://www.eurekaselect.com/article/81875","source":{"id":"https://openalex.org/S85221069","display_name":"Current Neuropharmacology","issn_l":"1570-159X","issn":["1570-159X","1875-6190"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:28228087","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28228087","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current neuropharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5652016","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5652016/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Curr Neuropharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.2174/1570159x15666170221101054","doi":"https://doi.org/10.2174/1570159x15666170221101054","is_oa":true,"landing_page_url":"https://doi.org/10.2174/1570159x15666170221101054","pdf_url":"http://www.eurekaselect.com/article/81875","source":{"id":"https://openalex.org/S85221069","display_name":"Current Neuropharmacology","issn_l":"1570-159X","issn":["1570-159X","1875-6190"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Neuropharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2589198547.pdf","grobid_xml":"https://content.openalex.org/works/W2589198547.grobid-xml"},"referenced_works_count":97,"referenced_works":["https://openalex.org/W1561342581","https://openalex.org/W1589051410","https://openalex.org/W1618080288","https://openalex.org/W1746596066","https://openalex.org/W1933633252","https://openalex.org/W1948877773","https://openalex.org/W1963927204","https://openalex.org/W1966918418","https://openalex.org/W1972183007","https://openalex.org/W1972972579","https://openalex.org/W1985791632","https://openalex.org/W1987239750","https://openalex.org/W1996357107","https://openalex.org/W1997113206","https://openalex.org/W2000752103","https://openalex.org/W2003982930","https://openalex.org/W2011199593","https://openalex.org/W2011804248","https://openalex.org/W2012199810","https://openalex.org/W2012827629","https://openalex.org/W2013881085","https://openalex.org/W2018114814","https://openalex.org/W2022994360","https://openalex.org/W2023081218","https://openalex.org/W2023187443","https://openalex.org/W2026135382","https://openalex.org/W2027590847","https://openalex.org/W2030343452","https://openalex.org/W2032184432","https://openalex.org/W2038338385","https://openalex.org/W2041828151","https://openalex.org/W2045893995","https://openalex.org/W2047397795","https://openalex.org/W2049022403","https://openalex.org/W2049563161","https://openalex.org/W2050559361","https://openalex.org/W2052617026","https://openalex.org/W2052665050","https://openalex.org/W2056041130","https://openalex.org/W2056406527","https://openalex.org/W2056462154","https://openalex.org/W2057360675","https://openalex.org/W2060150052","https://openalex.org/W2066439059","https://openalex.org/W2068026567","https://openalex.org/W2068032560","https://openalex.org/W2072990488","https://openalex.org/W2074907255","https://openalex.org/W2078842109","https://openalex.org/W2080326692","https://openalex.org/W2081070804","https://openalex.org/W2083681242","https://openalex.org/W2083947597","https://openalex.org/W2088572321","https://openalex.org/W2089351762","https://openalex.org/W2091363925","https://openalex.org/W2095159395","https://openalex.org/W2108466731","https://openalex.org/W2108980934","https://openalex.org/W2109334244","https://openalex.org/W2110960534","https://openalex.org/W2118826874","https://openalex.org/W2120091916","https://openalex.org/W2121117021","https://openalex.org/W2123488676","https://openalex.org/W2132324173","https://openalex.org/W2146170141","https://openalex.org/W2149402043","https://openalex.org/W2166921819","https://openalex.org/W2170086392","https://openalex.org/W2193974231","https://openalex.org/W2205288591","https://openalex.org/W2260293469","https://openalex.org/W2268719527","https://openalex.org/W2321735995","https://openalex.org/W2325139453","https://openalex.org/W2337679024","https://openalex.org/W2340538438","https://openalex.org/W2341561439","https://openalex.org/W2346390990","https://openalex.org/W2346471661","https://openalex.org/W2373469551","https://openalex.org/W2400771625","https://openalex.org/W2415986446","https://openalex.org/W2428350633","https://openalex.org/W2480067997","https://openalex.org/W2499491810","https://openalex.org/W2511226519","https://openalex.org/W2511756370","https://openalex.org/W2518780615","https://openalex.org/W2523939934","https://openalex.org/W2528777034","https://openalex.org/W2530887832","https://openalex.org/W2566965256","https://openalex.org/W2581419519","https://openalex.org/W2945792041","https://openalex.org/W2996459569"],"related_works":["https://openalex.org/W2552375956","https://openalex.org/W2346390990","https://openalex.org/W2587748623","https://openalex.org/W4308766369","https://openalex.org/W2346745491","https://openalex.org/W4200437000","https://openalex.org/W2950701273","https://openalex.org/W3061798809","https://openalex.org/W2521511395","https://openalex.org/W2410192602"],"abstract_inverted_index":{"BACKGROUND:":[0],"Ketamine":[1],"has":[2,23,62,102,114,157],"been":[3,63,103,115,158,191,200],"reported":[4,159],"to":[5,117,160,202,216],"exert":[6,118],"rapid":[7,204],"and":[8,32,54,74,76,98,137,184,198,245],"sustained":[9],"antidepressant":[10,122,147,165,205,238],"effects":[11,123,166,206],"in":[12,41,124,153,193],"patients":[13,17,194],"with":[14,18,51,195],"depression,":[15,197],"including":[16],"treatment-resistant":[19,196],"depression.":[20],"However,":[21],"ketamine":[22,130,229],"several":[24,135],"drawbacks":[25,219],"such":[26,150,179],"as":[27,105,142,180,243,248],"psychotomimetic/dissociative":[28],"symptoms,":[29],"abuse":[30],"potential":[31],"neurotoxicity,":[33],"all":[34],"of":[35,48,60,95,109,167,220,223,226,228,237],"which":[36],"prevent":[37],"its":[38],"routine":[39],"use":[40],"daily":[42],"clinical":[43],"practice.":[44],"METHODS:":[45],"Therefore,":[46],"development":[47,236],"novel":[49],"agents":[50,77,173,189],"fewer":[52],"safety":[53],"usage":[55],"concerns":[56],"for":[57,70,163,234],"the":[58,80,106,164,176,218,224,232,235],"treatment":[59],"depression":[61],"actively":[64],"investigated.":[65],"From":[66],"this":[67],"standpoint,":[68],"searching":[69],"active":[71,107,144],"substances":[72,145],"(stereoisomers":[73],"metabolites)":[75],"acting":[78,174,247],"on":[79,175],"N-methyl-D-aspartate":[81],"(NMDA)":[82],"receptor":[83],"have":[84,190,199],"recently":[85],"gained":[86],"much":[87],"attention.":[88],"RESULTS:":[89],"The":[90,169,210],"first":[91],"approach":[92,171],"includes":[93,172],"stereoisomers":[94],"ketamine,":[96,111],"(R)-ketamine":[97,113],"(S)-ketamine.":[99,128],"Although":[100],"(S)-ketamine":[101],"considered":[104],"stereoisomer":[108],"racemic":[110],"recently,":[112],"demonstrated":[116],"even":[119],"more":[120],"prolonged":[121],"animal":[125],"models":[126],"than":[127],"Moreover,":[129],"is":[131],"rapidly":[132,246],"metabolized":[133],"into":[134],"metabolites,":[136,151],"some":[138],"metabolites":[139],"are":[140,240],"speculated":[141],"being":[143],"exerting":[146],"effects.":[148],"Of":[149],"one":[152],"particular,":[154],"namely,":[155],"(2R,6R)-hydroxynorketamine,":[156],"be":[161,214],"responsible":[162],"ketamine.":[168,208,221,249],"second":[170],"NMDA":[177],"receptor,":[178],"glycine":[181],"site":[182],"modulators":[183],"GluN2B":[185],"subunit-selective":[186],"antagonists.":[187],"These":[188],"tested":[192],"found":[201],"exhibit":[203],"like":[207],"CONCLUSION:":[209],"above":[211],"approaches":[212],"may":[213,230],"useful":[215],"overcome":[217],"Elucidation":[222],"mechanisms":[225],"action":[227],"pave":[231],"way":[233],"that":[239],"safer,":[241],"but":[242],"potent":[244]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2589198547","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-03-03T00:00:00"}
